Clinical Trial Update: Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers Nano-SMART, a nanoparticle therapy with MR-guided SBRT being studied in centrally located lung tumors and pancreatic cancer (P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Pancreatic Adenocarcinoma

Drugs mentioned

• Nano-SMART

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Non-small Cell Lung Cancer, Advanced Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: RECRUITING